TransMedics

ANDOVER, MA · CIK 0001092287 · Medtech · Public

Organ Care System (OCS) - a perfusion device that preserves and monitors donor organs outside the body during transport for transplantation

transmedics.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$155M
9 Form D · May 2016
124 months since last filing
Contracts
$2.0M
13 awards · Veterans Affairs
#223 of 4531 in medtech
Patents
40
31 granted · 9 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$2,500,000
Private capital raisedForm D · SEC$3,573,982
Private capital raisedForm D · SEC$35,414,792
Private capital raisedForm D · SEC$5,922,498
Private capital raisedForm D · SEC$36,150,000
Private capital raisedForm D · SEC$29,965,776
Private capital raisedForm D · SEC$20,004,581
Private capital raisedForm D · SEC$499,998
Private capital raisedForm D · SEC$51,229,735
Federal contractDepartment of Veterans Affairs · Emergency Liver Transport$71,605
Federal contractDepartment of Veterans Affairs · Emergent Deceased Donor Liver Transportation And Perfusion$93,400
Federal contractDepartment of Veterans Affairs · Emergent Deceased Donor Organ Recovery Perfusion And Transportation$118,307
Federal contractDepartment of Veterans Affairs · Recovery Perfusion And Transportation Dcd Liver$95,850
Federal contractDepartment of Veterans Affairs · Deceased Donor Organ Recovery Perfusion And Transportation$140,370
Federal contractDepartment of Veterans Affairs · Deceased Donor Liver Recovery Profusion And Transportation$140,370
Federal contractDepartment of Veterans Affairs · Deceased Organ Donor Liver Recovery, Perfusion, And Transportation$114,001
Federal contractDepartment of Veterans Affairs · Deceased Donor Organ Recovery, Perfusion, And Transportation$280,740
Federal contractDepartment of Veterans Affairs · Deceased Donor Liver Recovery, Perfusion, And Transportation$131,069
Federal contractDepartment of Veterans Affairs · Deceased Donor Organ Recovery, Perfusion, And Transportation Emergency Liver Transport Services$140,370
Federal contractDepartment of Veterans Affairs · Deceased Donor Liver Recovery, Perfusion, And Transportation$105,471
Federal contractDepartment of Veterans Affairs · Deceased Donor Organ Recovery Perfusion And Transportation$280,740
Federal contractDepartment of Veterans Affairs · Deceased Donor Organ Recovery Perfusion And Transportation$280,740
Federal contract · USAspendingForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
220ATTUNE NEUROSCIENCES, INC.$2.0M—
221NEURONEXUS TECHNOLOGIES$2.0M—
222JUXTOPIA, LLC$2.0M—
223TransMedics$2.0M$155M
224Karius$2.0M—
225CSA Medical, Inc.$2.0M$157M
226VISTENDO INC$1.9M—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 25 related persons
  • David AbramDirector
  • David AbramsDirector
  • J. ArmstrongDirector
  • Edward BasileDirector
  • Kenneth BateDirector
  • Frederick BlumeDirector
  • Earl CollierDirector
  • Earl Collier, Jr.Director
  • Allan FergusonDirector
  • John GiannuzziDirector
  • James GilbertDirector
  • Stephen GordonExecutive Officer
  • Adam GrosserDirector
  • Waleed HassaneinDirector · Executive Officer
  • Edwin Kania, Jr.Director
  • Dmitry KobyzevDirector
  • Joseph LacobDirector
  • Domenic MicaleExecutive Officer
  • James RaoExecutive Officer
  • Travis RhodesDirector
  • Michael StanskyDirector
  • James TobinDirector
  • Richard van OostromDirector
  • Tony WhiteDirector
  • Magdi YacoubDirector

Patents

USPTO · 31 granted of 40

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.